Absci alternatives and competitors
The closest alternatives to Absci are Generate:Biomedicines, Antiverse, Chai Discovery and BigHat Biosciences.
Absci designs antibodies with generative AI and develops them as its own medicines and with partners.
10 alternatives to Absci
What each product does, with its price as the vendor publishes it.
-
G
Generate:Biomedicines, a Somerville, Massachusetts company founded by Flagship Pioneering in 2018 and listed on Nasdaq since February 2026, designs protein medicines with machine learning rather than finding them in nature.
Price: Not applicable
-
A
Antiverse designs antibodies with generative AI for G protein coupled receptors, ion channels and other membrane proteins that conventional antibody discovery struggles to reach, and sells that work to drug companies through research and licensing partnerships.
Price: No published price
-
C
San Francisco company that licenses foundation models for molecular design to pharmaceutical and life sciences research organizations, rather than using them to build its own pipeline.
Price: No published price
-
B
BigHat Biosciences, founded in San Mateo, California in 2019 by Mark DePristo and Peyton Greenside, designs and engineers antibodies with machine learning tied to its own automated laboratory, starting from an existing molecule, its own or a partner's, and improving it in rounds.
Price: No published price
-
N
Nabla Bio designs antibodies on a computer for pharmaceutical partners, then makes and tests them in its own lab.
Price: No published price
-
I
Insilico Medicine is a generative AI drug discovery company (HKEX: 3696), headquartered in Cambridge, Massachusetts with operations in Hong Kong, Abu Dhabi and Shanghai, that both licenses software and develops its own medicines.
Price: No published price
-
L
Latent Labs builds AI models that design proteins and antibodies from scratch, and runs them as a web platform that researchers can open in a browser.
Price: Free tier, then paid usage
-
B
Biolojic Design uses machine learning to design antibodies that do more than block a target: epitope specific agonists and antagonists, conditional binders, and what it calls multibodies, single symmetrical antibodies that bind more than one target on the same arm.
Price: No published price
-
M
Medvolt, based in Pune, India, sells MedGraph, an AI and physics based in silico platform for early drug discovery, to pharmaceutical and biotechnology companies as software modules and as delivered projects.
Price: No published price
-
E
Earendil Labs uses AI to design antibody drugs and develops them through its own pipeline, licensing individual programs to large pharmaceutical companies.
Price: No published price
Absci alternatives, answered
What are the best alternatives to Absci?
The closest alternatives to Absci are Generate:Biomedicines, Antiverse, Chai Discovery, BigHat Biosciences and Nabla Bio. Generate:Biomedicines, a Somerville, Massachusetts company founded by Flagship Pioneering in 2018 and listed on Nasdaq since February 2026, designs protein medicines with machine learning rather than finding them in nature. Antiverse designs antibodies with generative AI for G protein coupled receptors, ion channels and other membrane proteins that conventional antibody discovery struggles to reach, and sells that work to drug companies through research and licensing partnerships. BigHat Biosciences, founded in San Mateo, California in 2019 by Mark DePristo and Peyton Greenside, designs and engineers antibodies with machine learning tied to its own automated laboratory, starting from an existing molecule, its own or a partner's, and improving it in rounds.
Who are Absci's competitors?
Absci's competitors in the Drug Discovery AI category include Generate:Biomedicines, Antiverse, Chai Discovery, BigHat Biosciences, Nabla Bio and Insilico Medicine.